The purpose of this study was to identify the association between clinically relevant four-level cancer-related fatigue (CRF) and quality of life (QOL). This secondary data analysis included 152 participants who completed both the 0 to 1...
Several tyrosine kinase inhibitors (TKIs) are now approved for the treatment of chronic myeloid leukemia in chronic phase. The efficacy of these drugs has been repeatedly demonstrated, as has their tolerability in most patients. However,...
There has been an increase in the development of oral cancer agents in recent years. This has created a paradigm shift in the management of the adult oncology/hematology population as patients must assume increased responsibility for und...
Oncology patient visits are anticipated to increase annually as the population ages with an estimated 24,540 new cancer diagnoses in Colorado in 2015. This year, University of Colorado Anschutz Cancer Pavilion (ACP) visits have increased...
Background: Advanced practice nurses (APRNs) caring for prostate cancer patients in a community setting noted that bone health was not being monitored in patients receiving ADT. A review of published articles in early 2011 revealed littl...
Background: The Oncology Nurse Practitioner Web Education Resource (ONc-PoWER) is an online course developed by Margaret Rosenzweig, PhD, FNP-BC, AOCNP, from the University of Pittsburgh School of Nursing and funded by the National Cance...
As professionals, we pride ourselves on delivering high quality care. However, until five years ago, there was no method of demonstrating a practice’s level of excellence distinction from competing practices. In 2010, the Quality Oncolog...
Scope of Problem: Understanding care needs across the cancer trajectory requires sensitive communication about diagnosis, discussing factors influencing treatment decision-making, mediating family communication, and psychosocial counseli...
Objective: There is a knowledge gap between the capabilities of advocacy groups and healthcare providers (HCPs) and patients. The need to create awareness about valuable resources, available through not-for-profit organizations, for HCPs...
Introduction/Purpose: Utilization of established cancer screening guidelines ensures recommendations that are individualized to a patient’s level of risk. The purpose of this survey was to understand how APRNs in Texas access and utilize...
Peer Review is the evaluation of professionals by a peer who practices in a similar role and scope of practice. Yale New Haven Hospital (YNHH) Medical Staff Office utilizes ‘The Joint Commission’ ongoing professional practice evaluation ...
Background: Over 220,000 patients are diagnosed with lung cancer each year. Although only 15% are diagnosed at an early stage, with the possibility of curative surgery, this population numbers over 165,000 annual survivors. The purpose o...
Introduction: Targeted therapies for the treatment of metastatic NSCLC are associated with a distinct set of adverse side effects that differ clinically from those seen with chemotherapies. Our institution has been actively involved in c...
Introduction: Earlier this year, nivolumab, a fully human IgG4 anti–programmed death-1 (PD-1) immune checkpoint inhibitor antibody, gained approval for advanced-stage squamous-cell lung cancer in patients whose disease progressed after t...
Introduction/Background: Because multiple myeloma (MM) typically occurs in patients over 70 years of age, many patients present with comorbidities. This can present a challenge for the care team who must consider multiple factors which p...
Introduction: Multiple Myeloma (MM) treatment is undergoing rapid transformation. New agents and regimens create an increased need to proactively screen for, assess, and manage patient reported symptoms and concerns. The Carevive Care Pl...
Introduction: Significant changes to the multiple myeloma (MM) landscape have occurred within the past 10 years. Keeping up-to-date on drugs to treat MM and the management of side effects is challenging. The 2014 Multiple Myeloma Mentors...
Background: The Advanced Practitioner Society for Hematology and Oncology (APSHO) conducted a survey of its members over a 6 week period in the summer of 2014 to describe practice patterns. Significance of the Problem: Cancer survivors a...
Background: MDS represent a heterogeneous group of myeloid malignancies with variable prognosis. MDS are underdiagnosed, and many lower-risk patients are offered only supportive care (Khan AM. Am J Med. 2012;125[7 suppl]:S15-S7). This st...
Introduction: Oral mucositis refers to the damage of the mouth’s mucosa resulting from chemotherapy or radiation therapy. It is one of the most significantly debilitating, dose-limiting acute toxicities of cancer therapy that not only co...
Introduction: The advent of immune checkpoint inhibitors has substantially improved the treatment of advanced melanoma in the past 5 years. Ipilimumab was the first drug to prolong overall survival, while nivolumab and pembrolizumab have...
Introduction: Much of oncology care is now delivered through a team approach; understanding the potential benefits of the physician/APP collaborative unit, in addition to the value of the APP individually, has never been more important. ...
Advanced practice nurses have played a vital role in progressing and enhancing clinical practice. They have collaborated with many disciplines, including, but not limited to, medicine, biology, sociology, and psychology. These collaborat...
Introduction: Ipilimumab and nivolumab are immune checkpoint inhibitors approved for advanced melanoma. According to clinical trials, combination of these agents has greater efficacy compared with monotherapy. However, both nivolumab and...
Background: Dermatologic adverse events (dAE) can occur during and after all anticancer treatment regimens such as, but not limited to, rashes, nail abnormalities hand and feet symptoms, alopecia, xerosis, pruritus, radiation dermatitis,...
Integration of a first-in-class drug into clinical practice generates a need for information to support its safe and effective use. In the early days post-FDA approval, the amount of available information can be limited and knowing how t...
System and patient-based barriers lead to the inability of individuals to access appropriate treatment and oncologic care. Establishment of a homebound hematopoietic stem cell transplantation (HSCT) program promotes increased access to c...
Background and Specific Aims: As healthcare institutions transition to value-based payment systems, there is an increasing need to identify the true costs of delivering health services. The costing methodology Time-Driven Activity-Based ...
Introduction: A decade ago the Institute of Medicine recommended that every survivor receive a survivor care plan (SCP) yet despite endorsements of clinical merit, evidence is still evolving regarding SCP utility and value to patients. M...
